Table 2 Bladder capacity and symptom and pain scores according to the glomerulation grade.

From: Cystoscopic hydrodistention characteristics provide clinical and long-term prognostic features of interstitial cystitis after treatment

Glomerulation

MBC (ml)

CBC (ml)

ICSI

ICPI

OSS

VAS

0 (n = 26)

743 ± 170

321 ± 144

10.1 ± 4.0

10.6 ± 4.4

20.7 ± 7.9

3.67 ± 2.1

1 (n = 176)

746 ± 168

312 ± 122

11.7 ± 3.8

11.1 ± 3.46

22.8 ± 6.7

4.88 ± 2.4

2 (n = 218)

606 ± 153

279 ± 119

11.9 ± 4.05

11.0 ± 3.93

22.9 ± 7.5

4.31 ± 2.8

3 (n = 47)

593 ± 197

236 ± 87

13.1 ± 3.64

12.1 ± 3.42

25.2 ± 6.8

4.71 ± 2.6

HL (n = 19)

450 ± 138

179 ± 109

16.0 ± 4.33

13.7 ± 3.09

29.7 ± 7.3

6.83 ± 2.9

P value

0.000

0.000

0.002

0.099

0.010

0.017

P < 0.05

0,1 vs 2,3,4

HL vs all

HL vs 0,1,2

HL vs 0,1,2

 

HL vs 1,2

HL vs 2

  1. The data are presented as mean ± standard deviation. HL, Hunner’s lesions; MBC, maximal bladder capacity; CBC, cystometric bladder capacity; ICSI, Interstitial Cystitis Symptom Index; ICPI, Interstitial Cystitis Problem Index; OSS, O’Leary–Sant Symptom score; VAS, visual analog scale for pain (0–10).
  2. Higher urothelial dysfunction.